GlassScriptPrepare for your visit
Val Vogt
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) · Germantown, TN · NPI 1801811237
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,981.76
in general payments reported to CMS, 2019-2025 · $579 in 2025
The $579 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Who reported paying
General payments only, top 6 by amount.
- Axonics, INC. $1,505.62
- Amgen INC. $953.67
- Sumitomo Pharma America, INC. $675.16
- Astellas Pharma US INC $673.42
- Abbvie INC. $272.34
- Dendreon Pharmaceuticals LLC $189.90
Drugs and devices associated with these payments
Gemtesa Botox Orgovyx Provenge Myrbetriq Prolia Illuccix Prolaris Trelstar Luja Coude Jelmyto Keytruda
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Val Vogt listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/36261/val-vogt